Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The investigators aim to assess the respiratory effect of short half-life agents in balanced
anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea
syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus
a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable
polygraphies: the night before the surgery ; the first night following the surgery ; the
third night following the surgery.